Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,439,888
-
Share change
-
-1,823,774
-
Total reported value
-
$39,752,000
-
Price per share
-
$2.28
-
Number of holders
-
41
-
Value change
-
-$5,378,181
-
Number of buys
-
21
-
Number of sells
-
31
Institutional Holders of KALOBIOS PHARMACEUTICALS INC - COM (KBIO) as of Q2 2014
As of 30 Jun 2014,
KALOBIOS PHARMACEUTICALS INC - COM (KBIO) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,439,888 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, DEERFIELD MANAGEMENT CO, First Eagle Investment Management, LLC, FMR LLC, BVF INC/IL, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, GREAT POINT PARTNERS LLC, WALL STREET ASSOCIATES, VANGUARD GROUP INC, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.